{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:29:45Z","timestamp":1776752985958,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016R1A5A2012284"],"award-info":[{"award-number":["NRF-2016R1A5A2012284"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A2B6008455"],"award-info":[{"award-number":["NRF-2018R1A2B6008455"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI15C2524"],"award-info":[{"award-number":["HI15C2524"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00109-019-01762-4","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T10:28:47Z","timestamp":1552040927000},"page":"647-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Repositioning of the antipsychotic drug TFP for sepsis treatment"],"prefix":"10.1007","volume":"97","author":[{"given":"Jung Hwa","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Seob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gun-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Duk","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Min","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Heung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"issue":"6","key":"1762_CR1","first-page":"669","volume":"27","author":"H Chaudhry","year":"2013","unstructured":"Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M (2013) Role of cytokines as a double-edged sword in sepsis. In Vivo 27(6):669\u2013684","journal-title":"In Vivo"},{"key":"1762_CR2","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.3389\/fimmu.2018.02590","volume":"9","author":"M Bouras","year":"2018","unstructured":"Bouras M, Asehnoune K, Roquilly A (2018) Contribution of dendritic cell responses to sepsis-induced immunosuppression and to susceptibility to secondary pneumonia. Front Immunol 9:2590","journal-title":"Front Immunol"},{"issue":"5","key":"1762_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/01.SHK.0000092698.10326.6f","volume":"20","author":"P Efron","year":"2003","unstructured":"Efron P, Moldawer LL (2003) Sepsis and the dendritic cell. Shock 20(5):386\u2013401","journal-title":"Shock"},{"key":"1762_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molimm.2018.07.007","volume":"101","author":"V Kumar","year":"2018","unstructured":"Kumar V (2018) Dendritic cells in sepsis: potential immunoregulatory cells with therapeutic potential. Mol Immunol 101:615\u2013626","journal-title":"Mol Immunol"},{"key":"1762_CR5","first-page":"3591248","volume":"2017","author":"DD Wu","year":"2017","unstructured":"Wu DD, Li T, Ji XY (2017) Dendritic cells in sepsis: pathological alterations and therapeutic implications. J Immunol Res 2017:3591248","journal-title":"J Immunol Res"},{"issue":"10","key":"1762_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrd4368","volume":"13","author":"MP Fink","year":"2014","unstructured":"Fink MP, Warren HS (2014) Strategies to improve drug development for sepsis. Nat Rev Drug Discov 13(10):741\u2013758","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 1","key":"1762_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.shk.0000191343.21228.78","volume":"24","author":"JA Lorente","year":"2005","unstructured":"Lorente JA, Marshall JC (2005) Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 24(Suppl 1):107\u2013119","journal-title":"Shock"},{"issue":"8","key":"1762_CR8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, Ii M, Matsuda H, Mouri K, Cohen J (2010) A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 38(8):1685\u20131694","journal-title":"Crit Care Med"},{"issue":"10","key":"1762_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein CWEiSSsg (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699\u2013709","journal-title":"N Engl J Med"},{"issue":"7","key":"1762_CR10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1742-1241.2002.tb11315.x","volume":"56","author":"M Levi","year":"2002","unstructured":"Levi M, De Jonge E, van der Poll T (2002) Recombinant human activated protein C (Xigris). Int J Clin Pract 56(7):542\u2013545","journal-title":"Int J Clin Pract"},{"issue":"1","key":"1762_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/CCM.0b013e318192fe4f","volume":"37","author":"N Sennoun","year":"2009","unstructured":"Sennoun N, Meziani F, Dessebe O, Cattan V, Collin S, Montemont C, Gibot S, Asfar P, Ramaroson A, Regnault V, Slama M, Lecompte T, Lacolley P, Levy B (2009) Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med 37(1):246\u2013255","journal-title":"Crit Care Med"},{"issue":"2","key":"1762_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/sur.2017.264","volume":"19","author":"A Rajaee","year":"2018","unstructured":"Rajaee A, Barnett R, Cheadle WG (2018) Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis. Surg Infect 19(2):107\u2013116","journal-title":"Surg Infect"},{"issue":"9","key":"1762_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369(9):840\u2013851","journal-title":"N Engl J Med"},{"issue":"12","key":"1762_CR14","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/00003246-199812000-00045","volume":"26","author":"G Friedman","year":"1998","unstructured":"Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26(12):2078\u20132086","journal-title":"Crit Care Med"},{"key":"1762_CR15","first-page":"CD010226","volume":"1","author":"K Koch","year":"2014","unstructured":"Koch K, Mansi K, Haynes E, Adams CE, Sampson S, Furtado VA (2014) Trifluoperazine versus placebo for schizophrenia. Cochrane Database Syst Rev 1:CD010226","journal-title":"Cochrane Database Syst Rev"},{"key":"1762_CR16","first-page":"CD003545","volume":"1","author":"LO Marques","year":"2004","unstructured":"Marques LO, Lima MS, Soares BG (2004) Trifluoperazine for schizophrenia. Cochrane Database Syst Rev 1:CD003545","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1762_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nsb1194-795","volume":"1","author":"M Vandonselaar","year":"1994","unstructured":"Vandonselaar M, Hickie RA, Quail JW, Delbaere LT (1994) Trifluoperazine-induced conformational change in Ca(2+)-calmodulin. Nat Struct Biol 1(11):795\u2013801","journal-title":"Nat Struct Biol"},{"issue":"8","key":"1762_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0962-8924(00)01800-6","volume":"10","author":"D Chin","year":"2000","unstructured":"Chin D, Means AR (2000) Calmodulin: a prototypical calcium sensor. Trends Cell Biol 10(8):322\u2013328","journal-title":"Trends Cell Biol"},{"issue":"33","key":"1762_CR19","doi-asserted-by":"publisher","first-page":"25867","DOI":"10.1074\/jbc.M110.135632","volume":"285","author":"HJ Jung","year":"2010","unstructured":"Jung HJ, Kim JH, Shim JS, Kwon HJ (2010) A novel Ca2+\/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor. J Biol Chem 285(33):25867\u201325874","journal-title":"J Biol Chem"},{"issue":"5","key":"1762_CR20","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1210\/endo-119-5-2279","volume":"119","author":"A Nakai","year":"1986","unstructured":"Nakai A, Nagasaka A, Hidaka H, Tanaka T, Ohyama T, Iwase K, Ohtani S, Shinoda S, Aono T, Masunaga R et al (1986) Effect of calmodulin inhibitors on thyroid hormone secretion. Endocrinology 119(5):2279\u20132283","journal-title":"Endocrinology"},{"issue":"1","key":"1762_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0030-5898(20)31563-7","volume":"21","author":"SD Boden","year":"1990","unstructured":"Boden SD, Kaplan FS (1990) Calcium homeostasis. Orthop Clin N Am 21(1):31\u201342","journal-title":"Orthop Clin N Am"},{"issue":"2","key":"1762_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1189\/jlb.0707498","volume":"69","author":"BC Chen","year":"2001","unstructured":"Chen BC, Hsieh SL, Lin WW (2001) Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages. J Leukoc Biol 69(2):280\u2013288","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1762_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archsurg.1996.01430130046008","volume":"131","author":"CJ Lo","year":"1996","unstructured":"Lo CJ, Garcia I, Cryer HG, Maier RV (1996) Calcium and calmodulin regulate lipopolysaccharide-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. Arch Surg 131(1):44\u201350","journal-title":"Arch Surg"},{"issue":"1","key":"1762_CR24","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/CCM.0000000000002746","volume":"46","author":"B Dotson","year":"2018","unstructured":"Dotson B (2018) Calcium channel blockers and sepsis outcomes. Crit Care Med 46(1):e97\u2013e98","journal-title":"Crit Care Med"},{"issue":"9","key":"1762_CR25","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1097\/CCM.0000000000002550","volume":"45","author":"CC Lee","year":"2017","unstructured":"Lee CC, Lee MG, Lee WC, Lai CC, Chao CC, Hsu WH, Chang SS, Lee M (2017) Preadmission use of calcium channel blocking agents is associated with improved outcomes in patients with sepsis: a population-based propensity score-matched cohort study. Crit Care Med 45(9):1500\u20131508","journal-title":"Crit Care Med"},{"issue":"5","key":"1762_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1615\/CritRevImmunol.v31.i5.20","volume":"31","author":"M Rossol","year":"2011","unstructured":"Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, Hauschildt S (2011) LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 31(5):379\u2013446","journal-title":"Crit Rev Immunol"},{"issue":"6","key":"1762_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805\u2013820","journal-title":"Cell"},{"issue":"9","key":"1762_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1348-0421.12081","volume":"57","author":"HS Yim","year":"2013","unstructured":"Yim HS, Choi KM, Kim B, Jung ID, Park YM, Kang YK, Lee MG (2013) Effect of 1-methyl-D-tryptophan and adoptive transfer of dendritic cells on polymicrobial sepsis induced by cecal content injection. Microbiol Immunol 57(9):633\u2013639","journal-title":"Microbiol Immunol"},{"issue":"6917","key":"1762_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature01326","volume":"420","author":"J Cohen","year":"2002","unstructured":"Cohen J (2002) The immunopathogenesis of sepsis. Nature 420(6917):885\u2013891","journal-title":"Nature"},{"key":"1762_CR30","doi-asserted-by":"publisher","unstructured":"Kuzmich NN, Sivak KV, Chubarev VN, Porozov YB, Savateeva-Lyubimova TN, Peri F (2017) TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel) 5(4). https:\/\/doi.org\/10.3390\/vaccines5040034","DOI":"10.3390\/vaccines5040034"},{"issue":"7242","key":"1762_CR31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"BS Park","year":"2009","unstructured":"Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458(7242):1191\u20131195","journal-title":"Nature"},{"issue":"19","key":"1762_CR32","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1021\/bi1001213","volume":"49","author":"J Colomer","year":"2010","unstructured":"Colomer J, Schmitt AA, Toone EJ, Means AR (2010) Identification and inhibitory properties of a novel Ca(2+)\/calmodulin antagonist. Biochemistry 49(19):4244\u20134254","journal-title":"Biochemistry"},{"issue":"7","key":"1762_CR33","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1073\/pnas.78.7.4354","volume":"78","author":"H Hidaka","year":"1981","unstructured":"Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagata T (1981) N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A 78(7):4354\u20134357","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1762_CR34","first-page":"764","volume":"251","author":"M Asano","year":"1989","unstructured":"Asano M (1989) Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle. J Pharmacol Exp Ther 251(2):764\u2013773","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1762_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.immuni.2015.03.007","volume":"42","author":"J Dagvadorj","year":"2015","unstructured":"Dagvadorj J, Shimada K, Chen S, Jones HD, Tumurkhuu G, Zhang W, Wawrowsky KA, Crother TR, Arditi M (2015) Lipopolysaccharide induces alveolar macrophage necrosis via CD14 and the P2X7 receptor leading to interleukin-1alpha release. Immunity 42(4):640\u2013653","journal-title":"Immunity"},{"issue":"10","key":"1762_CR36","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.4049\/jimmunol.181.10.6803","volume":"181","author":"N Matzner","year":"2008","unstructured":"Matzner N, Zemtsova IM, Nguyen TX, Duszenko M, Shumilina E, Lang F (2008) Ion channels modulating mouse dendritic cell functions. J Immunol 181(10):6803\u20136809","journal-title":"J Immunol"},{"issue":"10","key":"1762_CR37","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41419-018-1046-3","volume":"9","author":"Z Feng","year":"2018","unstructured":"Feng Z, Xia Y, Gao T, Xu F, Lei Q, Peng C, Yang Y, Xue Q, Hu X, Wang Q, Wang R, Ran Z, Zeng Z, Yang N, Xie Z, Yu L (2018) The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis. Cell Death Dis 9(10):1006","journal-title":"Cell Death Dis"},{"issue":"1","key":"1762_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-017-0588-z","volume":"36","author":"X Zhang","year":"2017","unstructured":"Zhang X, Xu R, Zhang C, Xu Y, Han M, Huang B, Chen A, Qiu C, Thorsen F, Prestegarden L, Bjerkvig R, Wang J, Li X (2017) Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination. J Exp Clin Cancer Res 36(1):118","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1762_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1189\/jlb.0510286","volume":"90","author":"X Zhang","year":"2011","unstructured":"Zhang X, Guo L, Collage RD, Stripay JL, Tsung A, Lee JS, Rosengart MR (2011) Calcium\/calmodulin-dependent protein kinase (CaMK) Ialpha mediates the macrophage inflammatory response to sepsis. J Leukoc Biol 90(2):249\u2013261","journal-title":"J Leukoc Biol"},{"issue":"8","key":"1762_CR40","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673\u2013683","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01762-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:13:22Z","timestamp":1721056402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01762-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01762-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by and performed according to guidelines of the Institutional Animal Care and Use Committee (IACUC) of Konkuk University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}